United Therapeutics (UTHR) Tops Q1 EPS by 32c
Tweet
Share
E-mail
Get Alerts UTHR Hot Sheet
Price: $513.12 -1.51%
Financial Fact:
Interest expense: -500K
Today's EPS Names:
BTTX, VAXX, ELYS, More
Financial Fact:
Interest expense: -500K
Today's EPS Names:
BTTX, VAXX, ELYS, More
Join SI Premium – FREE
United Therapeutics (NASDAQ: UTHR) reported Q1 EPS of $4.86, $0.32 better than the analyst estimate of $4.54. Revenue for the quarter came in at $506.9 million versus the consensus estimate of $512.69 million.
For earnings history and earnings-related data on United Therapeutics (UTHR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
- Ross Stores, Inc. (ROST) PT Raised to $240 at Bernstein SocGen Group
- CoStar Group acquires Zonda for $800M, adding new home data
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
